, Chemokine (C-C motif) receptor 4; CCL17, Chemokine (C-C motif, CCR4, p.17
, MDC, p.22
, CLDN1, p.1
, Tregs, regulatory T cells
, AKT, v-akt murine thymoma viral oncogene homolog 1
,
,
Human Astrocytes; hCMEC/D3, Immortalized human brain endothelial cells; RT-qPCR, Quantitative real-time PCR ,
murine sarcoma viral oncogene homolog B1; CCR4 hi , CCR4 over expressing melanoma cells/CCR4 high; SFM, Serum Free Media; CM, Conditioned medium; DMSO ,
, Extracellular Matrix; FCS, Fetal calf serum, ECM
, Human brain-metastasizing melanoma cells, HBMMC
Tumor-microenvironment interactions: dangerous liaisons, Adv Cancer Res, vol.100, pp.203-232, 2008. ,
The role played by the microenvironment in site-specific metastasis, Cancer Lett, vol.352, pp.54-62, 2014. ,
The Metastatic Microenvironment, pp.15-38, 2013. ,
Generation and characterization of novel local and metastatic human neuroblastoma variants, Neoplasia, vol.10, pp.817-67, 2008. ,
The metastatic microenvironment: brainresiding melanoma metastasis and dormant micrometastasis, Int J Cancer, vol.131, pp.1071-82, 2012. ,
Chemokine-chemokine receptor axes in melanoma brain metastasis, Immunol Lett, vol.130, pp.107-121, 2010. ,
The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis, Int J Cancer, vol.136, pp.1296-307, 2015. ,
Chemokines: signal lamps for trafficking of T and B cells for development and effector function, J Leukoc Biol, vol.65, pp.6-15, 1999. ,
CCR4 and its ligands: from bench to bedside, Int Immunol, vol.27, pp.11-20, 2015. ,
CCR4 as a novel molecular target for immunotherapy of cancer, Cancer Science, vol.97, pp.1139-1146, 2006. ,
The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer, Ann Surg, vol.249, pp.933-974, 2009. ,
The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells, Int J Cancer, vol.131, pp.2509-2527, 2012. ,
Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells, Cancer Lett, vol.361, pp.86-96, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02411572
Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues, J Cell Sci, vol.125, pp.3015-3039, 2012. ,
Techniques for assessing 3-D cell-matrix mechanical interactions in vitro and in vivo, Exp Cell Res, vol.319, pp.2470-80, 2013. ,
Designer self-assembling Peptide nanofiber scaffolds for study of 3-d cell biology and beyond, Adv Cancer Res, vol.99, pp.335-62, 2008. ,
The selectin-selectin ligand axis in tumor progression, Cancer Metastasis Rev, vol.27, pp.19-30, 2008. ,
Astrocytes facilitate melanoma brain metastasis via secretion of IL-23, J Pathol, vol.236, pp.116-143, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02411573
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination, Proc Natl Acad Sci, vol.105, pp.10221-10227, 2008. ,
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens, Blood, vol.118, pp.4853-62, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00711130
Involvement of chemokine receptors in breast cancer metastasis, Nature, vol.410, pp.50-56, 2001. ,
Homeostatic chemokine receptors and organ-specific metastasis, Nat Rev Immunol, vol.11, pp.597-606, 2011. ,
Organ selectivity in metastasis: regulation by chemokines and their receptors, Clin Exp Metastasis, vol.25, pp.345-56, 2008. ,
Antichemokine immunotherapy for allergic diseases, Curr Opin Allergy Clin Immunol, vol.1, pp.561-568, 2001. ,
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome, Cancer Research, vol.69, pp.2000-2009, 2009. ,
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nature Medicine, vol.10, pp.942-949, 2004. ,
Clinical Application of Anti-CCR4 Monoclonal Antibody, Oncology, vol.89, pp.16-21, 2015. ,
The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer, Breast Cancer Res Treat, vol.131, pp.837-885, 2012. ,
Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells, Cancer Res, vol.69, pp.5996-6004, 2009. ,
RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4, Clin Exp Metastasis, vol.23, pp.9-18, 2006. ,
CCR4 promotes metastasis via ERK/NF-kappaB/MMP13 pathway and acts downstream of TNF-alpha in colorectal cancer, Oncotarget, vol.7, pp.47637-47649, 2016. ,
CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling, Int J Colorectal Dis, vol.28, pp.1479-87, 2013. ,
Tumorassociated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma, Med Oncol, vol.33, p.17, 2016. ,
Targeting CCR4 as an emerging strategy for cancer therapy and vaccines, Trends in Pharmacological Sciences, vol.35, pp.163-165, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455519
Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell, Am J Cancer Res, vol.5, pp.3072-84, 2015. ,
Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid, Melanoma Res, vol.24, pp.120-150, 2014. ,
Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion, J Immunol, vol.169, pp.2303-2315, 2002. ,
Intrinsic MDR-1 gene and P-glycoprotein expression in human melanoma cell lines, Int J Cancer, vol.59, pp.717-740, 1994. ,
,
Blood-brain barrier-specific properties www.impactjournals.com/oncotarget of a human adult brain endothelial cell line, Faseb Journal, vol.19, p.1872, 2005. ,
Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother Pharmacol, vol.24, pp.148-54, 1989. ,
A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses, PLoS One, vol.5, p.10431, 2010. ,